Understanding Preferences for Disease‐Modifying Drugs in Osteoarthritis
Authors:
Open Access
- 27 January 2014
- journal article
- research article
- Published by Wiley in Arthritis Care & Research
- Vol. 66 (8) , 1186-1192
Abstract
Objective: Numerous disease‐modifying drugs for osteoarthritis (DMOADs) are under investigation. However, patients' preferences for drugs to prevent progression of OA are not known. The objective of this study was to quantify patient preferences for potential DMOADs.Methods: We administered a conjoint analysis survey to 304 patients attending outpatient general medicine and specialty clinics. All patients seated in the waiting rooms were asked if they would participate in a survey to elicit opinions about arthritis treatments. We performed simulations to estimate preferences for 4 options to prevent worsening of knee OA: best case (pill, highest benefit, lowest risk, lowest cost), worst case (infusion, lowest benefit, highest risk, highest cost), moderate subcutaneous injection (injection, mid‐level benefit, mid‐level risk, mid‐level cost), and moderate infusion (same as subcutaneous injection except administered by infusion).Results: Subjects' median age was 57 years; 55% were women and 76% were white. Segmentation analyses revealed 4 patterns of preferences. A minority (5%) did not want to perform subcutaneous injections and would only consider DMOADs under the best‐case scenario. Approximately 20% were risk sensitive and were willing to take DMOADs under the best‐case scenario, but would start rejecting these medications as risk increased. A significant number rejected DMOADs under all conditions (16.4%); however, the largest segment (59.2%) had a strong preference for DMOADs across all scenarios.Conclusion: Our results suggest that a significant percentage of a nonselected outpatient population might be willing to accept at least a moderate degree of risk in order to prevent worsening knee OA.Keywords
Funding Information
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (AR060231-01)
This publication has 35 references indexed in Scilit:
- Patient Preferences and Willingness to Pay for Arthroplasty Surgery in Patients With Osteoarthritis of the HipThe Journal of Arthroplasty, 2012
- What proportion of patients report long-term pain after total hip or knee replacement for osteoarthritis? A systematic review of prospective studies in unselected patientsBMJ Open, 2012
- Investigating preferences for mosquito-control technologies in Mozambique with latent class analysisMalaria Journal, 2011
- Safety issues in the development of treatments for osteoarthritis: recommendations of the Safety Considerations Working GroupOsteoarthritis and Cartilage, 2011
- Introduction to OARSI FDA initiative OAC special editionOsteoarthritis and Cartilage, 2011
- Summary and recommendations of the OARSI FDA osteoarthritis Assessment of Structural Change Working GroupOsteoarthritis and Cartilage, 2011
- Responsiveness to change and reliability of measurement of radiographic joint space width in osteoarthritis of the knee: a systematic reviewOsteoarthritis and Cartilage, 2011
- Methodologic issues in clinical trials for prevention or risk reduction in osteoarthritisOsteoarthritis and Cartilage, 2011
- Evaluating the health and economic impact of osteoarthritis pain in the workforce: results from the National Health and Wellness SurveyBMC Musculoskeletal Disorders, 2011
- Measurement of change in function and disability in osteoarthritis: current approaches and future challengesCurrent Opinion in Rheumatology, 2009